Bri-Anne Wilson

Memorial Sloan-Kettering Cancer CenterNew York, New York - 10065 (646-888-0023) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2006

Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
May 2006 - June 2007
Lymphoma
Hodgkin Disease
Tnx-650



